{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:12:22Z","timestamp":1794071542261,"version":"4.8.0"},"reference-count":51,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2023]]},"abstract":"<jats:title>Abstract<\/jats:title>\n\t  <jats:p>Resistance to beta-lactam antimicrobials caused by extended-spectrum beta-lactamase (ESBL)-producing organisms is a global health concern. The objectives of this study were to (1) summarise the prevalence of potential ESBL-producing <jats:italic>Escherichia coli<\/jats:italic> (ESBL-EC) and <jats:italic>Salmonella<\/jats:italic> spp. (ESBL-SA) isolates from agrifood and human sources in Canada from 2012 to 2017, and (2) describe the distribution of ESBL genotypes among these isolates. All data were obtained from the Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS). CIPARS analysed samples for the presence of ESBLs through phenotypic classification and identified beta-lactamase genes (<jats:italic>bla<\/jats:italic><jats:sub>TEM<\/jats:sub>, <jats:italic>bla<\/jats:italic><jats:sub>SHV<\/jats:sub>, <jats:italic>bla<\/jats:italic><jats:sub>CTX<\/jats:sub>, <jats:italic>bla<\/jats:italic><jats:sub>OXA<\/jats:sub>, <jats:italic>bla<\/jats:italic><jats:sub>CMY\u22122<\/jats:sub>) using polymerase chain reaction (PCR) and whole genome sequencing (WGS). The prevalence of PCR-confirmed ESBL-EC in agrifood samples ranged from 0.5% to 3% across the surveillance years, and was detected most frequently in samples from broiler chicken farms. The overall prevalence of PCR-confirmed ESBL-SA varied between 1% and 4% between 2012 and 2017, and was most frequently detected in clinical isolates from domestic cattle. The TEM-CMY2 gene combination was the most frequently detected genotype for both ESBL-EC and ESBL-SA. The data suggest that the prevalence of ESBL-EC and ESBL-SA in Canada was low (i.e. &lt;5%), but ongoing surveillance is needed to detect emerging or changing trends.<\/jats:p>","DOI":"10.1017\/s0950268822001509","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T09:51:03Z","timestamp":1671529863000},"update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":20,"title":["Integrated surveillance of extended-spectrum beta-lactamase (ESBL)-producing <i>Salmonella<\/i> and <i>Escherichia coli<\/i> from humans and animal species raised for human consumption in Canada from 2012 to 2017"],"prefix":"10.1017","volume":"151","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6557-840X","authenticated-orcid":false,"given":"Courtney A.","family":"Primeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Bharat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol","family":"Janecko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2712-0961","authenticated-orcid":false,"given":"Carolee A.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mulvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Reid-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"McEwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"McWhirter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4526-9524","authenticated-orcid":false,"given":"E. Jane","family":"Parmley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2022,12,20]]},"reference":[{"key":"S0950268822001509_ref50","unstructured":"50. Centre for Disease Control and Prevention (2018) National antimicrobial resistance monitoring system for enteric bacteria (NARMS): Human isolates surveillance report for 2015 (final report). Available at https:\/\/www.cdc.gov\/narms\/reports\/annual-human-isolates-report-2015.html (Accessed 10 February 2022)."},{"key":"S0950268822001509_ref33","unstructured":"33. Government of Canada (2019) Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) 2017 Figures and Tables. Available at http:\/\/publications.gc.ca\/site\/eng\/9.879523\/publication.html (Accessed 31 May 2022)."},{"key":"S0950268822001509_ref35","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks295"},{"key":"S0950268822001509_ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2015.08.012"},{"key":"S0950268822001509_ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmm.2011.09.003"},{"key":"S0950268822001509_ref37","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku178"},{"key":"S0950268822001509_ref16","unstructured":"16. Primeau, C , (2020) Exploring the contributions of genotypic, phenotypic, social and qualitative data sources to our understanding of antimicrobial resistance in Canada. Guelph, Ontario, Canada: University of Guelph."},{"key":"S0950268822001509_ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(08)70041-0"},{"key":"S0950268822001509_ref30","unstructured":"30. Government of Canada (2016) Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) 2012 Annual Report, Chapter 3 \u2013 Antimicrobial use in animals. Available at https:\/\/publications.gc.ca\/collections\/collection_2017\/aspc-phac\/HP2-4-2013-3-eng.pdf (Accessed 31 May 2022)."},{"key":"S0950268822001509_ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijfoodmicro.2017.07.005"},{"key":"S0950268822001509_ref38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135402"},{"key":"S0950268822001509_ref48","doi-asserted-by":"publisher","DOI":"10.3382\/ps\/pex055"},{"key":"S0950268822001509_ref32","unstructured":"32. Government of Canada (2017) Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) 2015 Annual Report. Available at https:\/\/publications.gc.ca\/collections\/collection_2017\/aspc-phac\/HP2-4-2015-eng.pdf (Accessed 31 May 2022)."},{"key":"S0950268822001509_ref21","unstructured":"21. StataCorp (2017) Stata statistical software: release 15. College Station, TX: StataCorp LLC."},{"key":"S0950268822001509_ref22","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2017.0150"},{"key":"S0950268822001509_ref41","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-017-3000-1"},{"key":"S0950268822001509_ref2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.18.4.657-686.2005"},{"key":"S0950268822001509_ref7","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-14-187"},{"key":"S0950268822001509_ref10","doi-asserted-by":"publisher","DOI":"10.3109\/00365548.2011.632642"},{"key":"S0950268822001509_ref19","unstructured":"19. Clinical and Laboratory Standards Institute (2015) Performance standards for antimicrobial susceptibility testing; twenty fifth informational supplement."},{"key":"S0950268822001509_ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03497.x"},{"key":"S0950268822001509_ref23","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks349"},{"key":"S0950268822001509_ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2019.03.010"},{"key":"S0950268822001509_ref40","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01648-16"},{"key":"S0950268822001509_ref5","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks065"},{"key":"S0950268822001509_ref42","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02926-15"},{"key":"S0950268822001509_ref31","unstructured":"31. Government of Canada (2016) Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) 2014 Annual Report. Available at https:\/\/publications.gc.ca\/collections\/collection_2017\/aspc-phac\/HP2-4-2014-eng.pdf (Accessed 31 May 2022)."},{"key":"S0950268822001509_ref17","unstructured":"17. Government of Canada (2018) Canadian integrated program for antimicrobial resistance surveillance (CIPARS) 2016 annual report. Available at https:\/\/publications.gc.ca\/collections\/collection_2018\/aspc-phac\/HP2-4-2016-eng.pdf (Accessed 31 May 2022)."},{"key":"S0950268822001509_ref18","unstructured":"18. Clinical and Laboratory Standards Institute (2017) M100 performance standards for antimicrobial susceptibility testing an informational supplement for global application developed through the clinical and laboratory standards institute consensus process."},{"key":"S0950268822001509_ref13","doi-asserted-by":"publisher","DOI":"10.1186\/1746-6148-8-21"},{"key":"S0950268822001509_ref24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1292\/jvms.11-0372","article-title":"Prevalence of extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae in food-producing animals","volume":"74","author":"Hiroi","year":"2012","journal-title":"Journal of Veterinary Medical Science"},{"key":"S0950268822001509_ref44","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr507"},{"key":"S0950268822001509_ref34","doi-asserted-by":"publisher","DOI":"10.1017\/S1466252317000020"},{"key":"S0950268822001509_ref51","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.13310"},{"key":"S0950268822001509_ref28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179384"},{"key":"S0950268822001509_ref14","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx397"},{"key":"S0950268822001509_ref20","unstructured":"20. National Microbiology Laboratory (2018) Staramr. Available at https:\/\/github.com\/phac-nml\/staramr (Accessed 31 May 2022)."},{"key":"S0950268822001509_ref43","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01251-15"},{"key":"S0950268822001509_ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2014.01.030"},{"key":"S0950268822001509_ref29","unstructured":"29. Government of Canada (2015) Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) 2012 Annual Report, Chapter 3 \u2013 Antimicrobial use in animals. Available at https:\/\/publications.gc.ca\/collections\/collection_2015\/aspc-phac\/HP2-4-2012-3-eng.pdf (Accessed 31 May 2022)."},{"key":"S0950268822001509_ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.prevetmed.2012.02.020"},{"key":"S0950268822001509_ref27","unstructured":"27. Turkey Farmers of Canada (2022) Antibiotics: your questions answered. Available at https:\/\/www.turkeyfarmersofcanada.ca\/on-the-farm\/antibiotics\/ (Accessed 27 May 2022)."},{"key":"S0950268822001509_ref26","unstructured":"26. Chicken Farmers of Canada (2022) Questions and answers. Available at https:\/\/www.chickenfarmers.ca\/faq\/ (Accessed 27 May 2022)."},{"key":"S0950268822001509_ref3","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taw102"},{"key":"S0950268822001509_ref4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1086\/649537","article-title":"Community-onset bacteremia due to extended-spectrum \u03b2-lactamase-producing Escherichia coli: risk factors and prognosis","volume":"50","author":"Rodr\u00edguez-Ba\u00f1o","year":"2010","journal-title":"Clinical Infectious Diseases"},{"key":"S0950268822001509_ref8","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx488"},{"key":"S0950268822001509_ref25","unstructured":"25. Government of Canada (2009) Categorization of antimicrobial drugs based on importance in human medicine. Available at https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/veterinary-drugs\/antimicrobial-resistance\/categorization-antimicrobial-drugs-based-importance-human-medicine.html (Accessed 25 May 2022)."},{"key":"S0950268822001509_ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2017.10.014"},{"key":"S0950268822001509_ref49","unstructured":"49. Centre for Disease Control and Prevention (2016) National antimicrobial resistance monitoring system for enteric bacteria (NARMS): Human isolates surveillance report for 2014 (final report). Available at https:\/\/www.cdc.gov\/narms\/reports\/annual-human-isolates-report-2014.html (Accessed 12 February 2022)."},{"key":"S0950268822001509_ref15","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00488-17"},{"key":"S0950268822001509_ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.01.013"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268822001509","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T04:24:05Z","timestamp":1674707045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268822001509\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,20]]},"references-count":51,"alternative-id":["S0950268822001509"],"URL":"https:\/\/doi.org\/10.1017\/s0950268822001509","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,20]]},"assertion":[{"value":"Copyright \u00a9 CROWN Copyright \u2013 Her Majesty the Queen in Right of Canada as Represented by the Minister of Health, 2022. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http:\/\/creativecommons.org\/licenses\/by\/4.0\/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"e14"}}